Safety of Human USH1C Transgene Expression Following Subretinal Injection in Wild-Type Pigs

. 2025 Jan 02 ; 66 (1) : 48.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39836403

PURPOSE: This study aimed to evaluate early-phase safety of subretinal application of AAVanc80.CAG.USH1Ca1 (OT_USH_101) in wild-type (WT) pigs, examining the effects of a vehicle control, low dose, and high dose. METHODS: Twelve WT pigs (24 eyes) were divided into three groups: four pigs each received bilateral subretinal injections of either vehicle, low dose (3.3 × 1010 vector genomes [vg] per eye), or high dose (1.0 × 1011 vg per eye). Total retinal thickness (TRT) was evaluated using optical coherence tomography and retinal function was assessed with full-field electroretinography (ff-ERG) at baseline and two months post-surgery. After necropsy, retinal changes were examined through histopathology, and human USH1C_a1/harmonin expression was assessed by quantitative PCR (qPCR) and Western blotting. RESULTS: OT_USH_101 led to high USH1C_a1 expression in WT pig retinas without significant TRT changes two months after subretinal injection. The qPCR revealed expression of the human USH1C_a1 transgene delivered by the adeno-associated virus vector. TRT changes were minimal across groups: vehicle (256 ± 21 to 243 ± 18 µm; P = 0.108), low dose (251 ± 32 to 258 ± 30 µm; P = 0.076), and high dose (242 ± 24 to 259 ± 28 µm; P = 0.590). The ff-ERG showed no significant changes in rod or cone responses. Histopathology indicated no severe retinal adverse effects in the vehicle and low dose groups. CONCLUSIONS: Early-phase clinical imaging, electrophysiology, and histopathological assessments indicated that subretinal administration of OT_USH_101 was well tolerated in the low-dose treatment arm. OT_USH_101 treatment resulted in high expression of human USH1C_a1. Although histopathological changes were not severe, more frequent changes were observed in the high-dose group.

Zobrazit více v PubMed

Millán JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, Ayuso C.. An update on the genetics of usher syndrome. PubMed PMC

Vernon M. Usher's syndrome–deafness and progressive blindness. Clinical cases, prevention, theory and literature survey. PubMed

Boughman JA, Vernon M, Shaver KA.. Usher syndrome: definition and estimate of prevalence from two high-risk populations. PubMed

Marazita ML, Ploughman LM, Rawlings B, Remington E, Arnos KS, Nance WE. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. PubMed

Delmaghani S, El-Amraoui A.. The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification. PubMed PMC

Ullah F, Zeeshan Ali M, Ahmad S, et al.. Current updates on genetic spectrum of Usher syndrome [published online ahead of print May 8, 2024]. PubMed DOI

Fuster-García C, García-Bohórquez B, Rodríguez-Muñoz A, et al.. Usher syndrome: genetics of a human ciliopathy. PubMed PMC

Whatley M, Francis A, Ng ZY, et al.. Usher syndrome: genetics and molecular links of hearing loss and directions for therapy. PubMed PMC

Nisenbaum E, Thielhelm TP, Nourbakhsh A, et al.. Review of genotype-phenotype correlations in Usher syndrome. PubMed PMC

Nagel-Wolfrum K, Fadl BR, Becker MM, et al.. Expression and subcellular localization of USH1C/harmonin in human retina provides insights into pathomechanisms and therapy. PubMed PMC

Schäfer J, Wenck N, Janik K, et al.. The Usher syndrome 1C protein harmonin regulates canonical Wnt signaling. PubMed PMC

de Joya EM, Colbert BM, Tang PC, et al.. Usher syndrome in the inner ear: etiologies and advances in gene therapy. PubMed PMC

Leroy BP, Fischer MD, Flannery JG, et al.. Gene therapy for inherited retinal disease: long-term durability of effect. PubMed

Cheng SY, Punzo C.. Update on viral gene therapy clinical trials for retinal diseases. PubMed PMC

French LS, Mellough CB, Chen FK, Carvalho LS.. A review of gene, drug and cell-based therapies for Usher syndrome. PubMed PMC

Martinez Velazquez LA, Ballios BG. The next generation of molecular and cellular therapeutics for inherited retinal disease. PubMed PMC

Lentz J, Pan F, Ng SS, Deininger P, Keats B.. Ush1c216A knock-in mouse survives Katrina. PubMed

Lentz JJ, Jodelka FM, Hinrich AJ, et al.. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. PubMed PMC

Pan B, Askew C, Galvin A, et al.. Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c. PubMed PMC

Grotz S, Schäfer J, Wunderlich KA, et al.. Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes. PubMed PMC

Vodicka P, Smetana K Jr., Dvoránková B, et al.. The miniature pig as an animal model in biomedical research. PubMed

Sedmak T, Wolfrum U.. Intraflagellar transport proteins in ciliogenesis of photoreceptor cells. PubMed

Reiners J, Reidel B, El-Amraoui A, et al.. Differential distribution of harmonin isoforms and their possible role in Usher-1 protein complexes in mammalian photoreceptor cells. PubMed

Overlack N, Kilic D, Bauss K, et al.. Direct interaction of the Usher syndrome 1G protein SANS and myomegalin in the retina. PubMed

Lewis GP, Charteris DG, Sethi CS, Fisher SK.. Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. PubMed

Christoforidis J, Ricketts R, Loizos T, Chang S. Optical coherence tomography findings of quinine poisoning. PubMed PMC

Wenzel DA, Kromer R, Poli S, et al.. Optical coherence tomography-based determination of ischaemia onset—the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion. PubMed

Regatieri CV, Alwassia A, Zhang JY, Vora R, Duker JS.. Use of optical coherence tomography in the diagnosis and management of uveitis. PubMed PMC

Goldenberg D, Goldstein M, Loewenstein A, Habot-Wilner Z.. Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography. PubMed

Chiang TK, White KM, Kurup SK, Yu M.. Use of visual electrophysiology to monitor retinal and optic nerve toxicity. PubMed PMC

Hassan-Karimi H, Jafarzadehpur E, Blouri B, Hashemi H, Sadeghi AZ, Mirzajani A.. Frequency domain electroretinography in retinitis pigmentosa versus normal eyes. PubMed PMC

Ebdali S, Hashemi B, Hashemi H, Jafarzadehpur E, Asgari S. Time and frequency components of ERG responses in retinitis pigmentosa. PubMed

Negro Silva LF, Li C, de Seadi Pereira PJB, et al.. Biochemical and electroretinographic characterization of the minipig eye in the context of drug safety investigations. PubMed

Augsburger AS, Haag V, Leuillet S, Legrand JJ, Forster R.. Recording of the full-field electroretinogram in minipigs. PubMed

Maya-Vetencourt JF, Di Marco S, Mete M, et al.. Biocompatibility of a conjugated polymer retinal prosthesis in the domestic pig. PubMed PMC

Al Mouiee D, Meijering E, Kalloniatis M, et al.. Classifying retinal degeneration in histological sections using deep learning. PubMed PMC

Mecklenburg L, Schraermeyer U.. An overview on the toxic morphological changes in the retinal pigment epithelium after systemic compound administration. PubMed

Ramadan RT, Ramirez R, Novosad BD, Callegan MC.. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. PubMed

Iandiev I, Uckermann O, Pannicke T, et al.. Glial cell reactivity in a porcine model of retinal detachment. PubMed

Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. PubMed PMC

El-Amraoui A, Petit C.. The retinal phenotype of Usher syndrome: pathophysiological insights from animal models. PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace